David De Weese Net Worth

The estimated Net Worth of Weese David H De is at least $174 millier dollars as of 18 June 2020. Mr. De owns over 8,169 units of GWG Inc stock worth over $23,608 and over the last 5 years he sold GWGH stock worth over $0. In addition, he makes $150,000 as Director at GWG Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Weese GWGH stock SEC Form 4 insiders trading

David has made over 1 trades of the GWG Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 8,169 units of GWGH stock worth $23,608 on 18 June 2020.

The largest trade he's ever made was exercising 8,169 units of GWG Inc stock on 18 June 2020 worth over $23,608. On average, David trades about 4,085 units every 0 days since 2019. As of 18 June 2020 he still owns at least 8,169 units of GWG Inc stock.

You can see the complete history of Mr. De stock trades at the bottom of the page.

David De Weese biography

David H. De Weese serves as Director of the Company. Mr. de Weese is a Partner of Paul Capital Advisors, a private equity firm. He was instrumental in developing Paul Capital’s deal origination strategy and transaction sourcing network. He joined Paul Capital in 1995 and led global secondary transaction sourcing activities and the due diligence of life science and health care investments. Mr. de Weese has 14 years of management experience in Europe. He has an extensive entrepreneurial experience and in-depth scientific and business knowledge. He also founded Medical Innovations. In 1993, he co-founded and served as the President and Chief Executive Officer of M6 Pharmaceuticals. Mr. de Weese served as the President and Chief Executive Officer of Cygnus Therapeutic Systems, SigA Pharmaceuticals and a Silicon Valley software company. Prior to Cygnus, he served as the President and Chief Executive Officer of Machine Intelligence Corporation. Mr. de Weese served as Director of OSE Immunotherapeutics SA (also known as OSE Pharma SA) from June 2014 to June 2017. Mr. de Weese holds an M.B.A. from the Harvard Business School, a B.A. from Stanford University and attended law school at Stanford University.

What is the salary of David Weese?

As the Director of GWG Inc, the total compensation of David Weese at GWG Inc is $150,000. There are 6 executives at GWG Inc getting paid more, with Timothy L. Evans J.D. having the highest compensation of $4,327,411.

How old is David Weese?

David Weese is 77, he's been the Director of GWG Inc since 2019. There are no older and 12 younger executives at GWG Inc.

What's David Weese's mailing address?

Weese's mailing address filed with the SEC is 325 NORTH ST. PAUL STREET, SUITE 2650, DALLAS, TX, 555402.

Insiders trading at GWG Inc

Over the last 10 years, insiders at GWG Inc have traded over $0 worth of GWG Inc stock and bought 200,000 units worth $2,500,000 . The most active insiders traders include Thomas O Hicks, Dennis P Lockhart et Shawn R Gensch. On average, GWG Inc executives and independent directors trade stock every 150 days with the average trade being worth of $127,781. The most recent stock trade was executed by Bruce William Schnitzer on 18 June 2020, trading 8,169 units of GWGH stock currently worth $23,608.

What does GWG Inc do?

GWG Holdings, Inc. is an innovative financial services firm based in Dallas, Texas that is a leader in providing investments that are non-correlated to the traded markets, and unique liquidity solutions and services for the owners of illiquid investments. Through its subsidiaries, The Beneficient Company Group, L.P.and GWG Life, LLC,GWGH owns and manages a diverse portfolio of alternative assets that, as of September 30, 2020, included $1.9 billion in life insurance policy benefits, and exposure to a diversified and growing loan portfolio secured by 122 professionally managed alternative investment funds.

Complete history of Mr. De stock trades at GWG Inc

GWG Inc executives and stock owners

GWG Inc executives and other stock owners filed with the SEC include:

• Timothy L. Evans J.D.,
  CFO, Treasurer & Director
• Murray T. Holland,
  Pres, CEO & Chairman
• Murray Holland,
  President, Chief Executive Officer
• Timothy Evans,
  Chief Financial Officer, Treasurer
• David Chaveson,
  Independent Director
• Peter Cangany,
  Independent Director
• David De Weese,
  Director
• Thomas Hicks,
  Director
• Bruce Schnitzer,
  Director
• Bradley Heppner,
  Chairman of the Board
• Dennis Lockhart,
  Independent Director
• Dan Callahan,
  Director - Communication
• Roy Bailey,
  Independent Director
• Daniel Fine,
  Director
• Lennie Nicholson,
  General Counsel
• Ben Hilgers,
  Regional Vice President - Florida and Puerto Rico
• Michele Drummond,
  Vice President - National Accounts
• Jenniffer Daigle,
  Sr. VP of Bus. Devel.
• Merriah Harkins,
  Exec. VP of Retail Capital Markets
• Jon Gangelhoff,
  Chief Operating Officer
• Jeffrey L. Mc Gregor,
  Director
• William Acheson,
  Chief Financial Officer
• Shawn R Gensch,
  Director
• Jon Sabes,
  Chief Executive Officer
• Charles H Iii Maguire,
  Director
• Steven F Sabes,
  Exec VP & Secretary
• Mark Edward Schwarzmann,
  Director
• David H Abramson,
  Director
• Thomas J Jr Donohue,
  Director
• David Chavenson,
  Director
• Brad K Heppner,
  Director
• Richard W Fisher,
  Director
• Bruce Zimmerman,
  Director
• Michelle Caruso Cabrera,
  Director
• Roger T Staubach,
  Director
• David Glaser,
  Director
• Kathleen Mason,
  Director
• Sheldon I Stein,
  Director
• Paul A Siegert,
  Chairman